Valuation: Avantor, Inc.

Market Cap 7.05B 6.16B 5.66B 5.28B 10B 671B 10.15B 67.95B 26.41B 329B 26.45B 25.88B 1,137B P/E 2026 *
28.7x
P/E 2027 * 23.9x
Enterprise Value 10.06B 8.8B 8.07B 7.54B 14.28B 958B 14.49B 97B 37.7B 470B 37.76B 36.94B 1,623B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.42x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 50 2026-06-23
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 70 2025-12-31
Director/Board Member 62 2021-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 7.05B
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.78B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average +2.68%+4.67%+6.30%+0.29% 59.87B
Weighted average by Cap. +3.28%+3.80%-3.84%+1.05%

Financials

2026 *2027 *
Net sales 6.5B 5.69B 5.22B 4.87B 9.23B 619B 9.37B 62.71B 24.37B 304B 24.41B 23.88B 1,049B 6.64B 5.81B 5.33B 4.97B 9.43B 632B 9.57B 64.03B 24.89B 310B 24.93B 24.38B 1,071B
Net income 244M 213M 196M 183M 346M 23.22B 351M 2.35B 914M 11.4B 916M 896M 39.35B 289M 253M 232M 217M 410M 27.51B 416M 2.79B 1.08B 13.51B 1.09B 1.06B 46.63B
Net Debt 3.01B 2.63B 2.42B 2.26B 4.28B 287B 4.34B 29.05B 11.29B 141B 11.31B 11.06B 486B 2.36B 2.07B 1.9B 1.77B 3.35B 225B 3.4B 22.78B 8.86B 110B 8.87B 8.68B 381B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-